Financial statements Biodragon
Balance sheet data of BIODRAGON
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 176 592,72 | 321 910,72 | 3 677 096,30 | 3 881 413,42 | 4 001 896,54 | 3 571 785,26 |
| A. Fixed assets | 39 533,15 | 101 869,15 | 3 484 352,48 | 3 409 302,40 | 3 228 185,24 | 3 045 585,26 |
| B. Current assets | 137 059,57 | 220 041,57 | 192 743,82 | 472 111,02 | 773 711,30 | 526 200,00 |
| C. Share capital contributions (basic funds) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 176 592,72 | 321 910,72 | 3 677 096,30 | 3 881 413,42 | 4 001 896,54 | 3 571 785,26 |
| A. Equity | 49 218,44 | 195 384,26 | 309 352,34 | 832 582,63 | 1 061 097,58 | 1 178 315,04 |
| B. Liabilities and provisions for liabilities | 127 374,28 | 126 526,46 | 3 367 743,96 | 3 048 830,79 | 2 940 798,96 | 2 393 470,22 |
| I. Long-term liabilities | - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 118 824,38 | 117 509,94 | 1 167 332,14 | 812 683,79 | 804 670,76 | 364 968,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.